Scienture Holdings, Inc. (Nasdaq: SCNX) has entered into a securities purchase agreement for the sale of 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds from the offering are expected to be approximately $3.9 million before expenses.
Maxim Group LLC is the sole placement agent for this offering.
Offering Details
3,225,000 shares of common stock at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million before expenses.
Placement Agent
Maxim Group LLC is acting as the sole placement agent.
- The offering is expected to provide significant capital to Scienture Holdings, Inc.
- This transaction demonstrates investor confidence in the company's growth potential.
This registered direct offering signifies a strategic move for Scienture Holdings, Inc. to raise capital and support its pharmaceutical operations. The involvement of institutional investors highlights the market's interest in the company's future prospects.